MCA
PFE icon

Metropolitan Capital Advisors’s Pfizer PFE Stock Holding History

Metropolitan Capital Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-67,351
Closed -$2.22M – 48
2015
Q1 		$2.22M Sell
67,351
-112,461
-63% -$3.58M 1.94% 18
2014
Q4 		$5.31M Sell
179,812
-257,282
-59% -$7.38M 5.07% 6
2014
Q3 		$12.3M Buy
+437,094
New +$12.3M 11.1% 1

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Metropolitan Capital Advisors's PFE Position: Q4 2015 in Review

Metropolitan Capital Advisors sold out of Pfizer (PFE) in Q4 2015, closing a stake of 33,833 shares — an estimated $1.01M sold.

Metropolitan Capital Advisors first reported a position in PFE in Q1 2015 and held it in 3 quarters. The position peaked at $1.07M in Q2 2015. 1,970 funds tracked by Wall St. Rank hold PFE as of Q4 2015.

  • Metropolitan Capital Advisors reported no remaining Pfizer position as of Q4 2015 after selling out during the quarter.
  • Metropolitan Capital Advisors sold 33,833 Pfizer shares in Q4 2015, an estimated $1.01M.
  • Metropolitan Capital Advisors first reported a position in Pfizer in Q1 2015 and held it in 3 quarters.
  • Metropolitan Capital Advisors's Pfizer position peaked at $1.07M in Q2 2015.
  • 1,970 funds tracked by Wall St. Rank held Pfizer as of Q4 2015.

Based on Metropolitan Capital Advisors's 13F filing for Q4 2015, filed 16 Feb 2016.